Show an ad over header. AMP

I am the second

Winter coronavirus threat spurs new surge of startup activity

U.S. coronavirus cases and hospitalizations are surging, with cold weather arriving before even the best-case scenario for a widely distributed vaccine. Now we're also beginning to see an increase in coronavirus-related startup funding, focused on both testing and pharma.

Driving the news: Gauss, a Silicon Valley computer vision startup focused on health care, tells Axios that it's raised $10 million to accelerate development and commercialization of an at-home rapid antigen test for COVID-19.

Keep reading...Show less

Related Articles

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories